Half of HIV-infected get treatment now: UNAIDS
The latest report of UNAIDS reveals that more than half of all People Living with HIV now have access to HIV treatment. Further, AIDS-related deaths have almost halved since 2005. Since the global onset of the HIV/AIDS epidemic, it is for the first time that the scales have tipped in favor of the patients.
Executive Director of UNAIDS stated that they will continue to scale up, with an aim to reach everyone in need and honour our commitment of leaving no one behind.
The report, Ending AIDS: Progress towards the 90–90–90 target, is the annual scorecard for progress. The idea behind the 90-90-90 target is to diagnose 90% of people who are HIV positive, get 90% of the diagnosed HIV+ people on antiretroviral treatment, and 90% of those on antiretrovirals should be virally suppressed.
- United Nations programme on HIV and AIDS (UNAIDS) is the main advocate for an accelerated, comprehensive and coordinated global action on the HIV/AIDS pandemic
- Preventing transmission of HIV, providing care and support to those that have already been infected by the virus, reducing the vulnerability of individuals and communities to HIV
- UNAIDS has five goals:
- Provide leadership for effective action on the pandemic
- Strategic information and technical support against AIDS worldwide
- Tracking, monitoring and evaluation of the pandemic
- Civil society engagement and the development of strategic partnerships
- Mobilization of resources to support an effective response
New infections in India:
- Nearly 95 per cent of the cases in 2016 were concentrated in just 10 countries, India being one of them
- India is the country where most new HIV infections are occurring in the Asia-Pacific region
- While India has made big progress with new infections dropping significantly, the emergence of HIV in some locations that were earlier considered not high-burden areas is a cause for concern
Challenges that need to be overcome:
- Insufficient availability and poor affordability of essential medicines in low and middle income countries remain major barriers
- Averting market failures to is highly significant. Actions that focus on the intersections between intellectual property rights, innovation, and public health are vitally important for resolving market failures in medicine development and manufacture
- This assumes significance as the generic pharmaceutical industry is concentrated in India, and the global AIDS response’s continued reliance on the Indian industry